We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+10.27%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$22.8B
AUM Growth
-$510M
Cap. Flow
-$2.26B
Cap. Flow %
-9.9%
Top 10 Hldgs %
40.08%
Holding
187
New
21
Increased
43
Reduced
39
Closed
22

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$207M
2
ANSS
Ansys
ANSS
+$201M
3
WWD icon
Woodward
WWD
+$192M
4
SWN
Southwestern Energy Company
SWN
+$168M
5
SQSP
Squarespace, Inc.
SQSP
+$130M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$294M
2
NDAQ icon
Nasdaq
NDAQ
+$256M
3
CRM icon
Salesforce
CRM
+$231M
4
AZN icon
AstraZeneca
AZN
+$188M
5
ARMK icon
Aramark
ARMK
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 31.84%
2 Technology 13.48%
3 Financials 9.84%
4 Communication Services 6.79%
5 Industrials 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
51
Tenet Healthcare
THC
$21.1B
$115M 0.5%
692,442
+5,000
+0.7% +$756K
LBPH
52
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$105M 0.46%
3,150,857
+210,357
+7% +$7.24M
DFS
53
DELISTED
Discover Financial Services
DFS
$102M 0.45%
725,000
+565,000
+353% +$76M
BEKE icon
54
KE Holdings
BEKE
$18.8B
$94.4M 0.41%
4,740,833
– –
X
55
DELISTED
US Steel
X
$85M 0.37%
2,405,000
+695,000
+41% +$26.5M
ICLR icon
56
Icon
ICLR
$12.7B
$63.4M 0.28%
220,800
+42,600
+24% +$13.4M
CRNX icon
57
Crinetics Pharmaceuticals
CRNX
$8.92B
$59.4M 0.26%
1,162,000
+665,000
+134% +$34.3M
CHX
58
DELISTED
ChampionX
CHX
$58.9M 0.26%
1,955,000
+1,170,000
+149% +$37M
COR icon
59
Cencora
COR
$61.2B
$52.9M 0.23%
235,200
-7,600
-3% -$1.76M
IBIT icon
60
iShares Bitcoin Trust
IBIT
$48.4B
$52M 0.23%
+1,440,000
New +$50M
LBRDK icon
61
Liberty Broadband Class C
LBRDK
$5.15B
$51M 0.22%
+660,000
New +$40.8M
JNPR
62
DELISTED
Juniper Networks
JNPR
$50.1M 0.22%
+1,285,000
New +$49M
HR icon
63
Healthcare Realty
HR
$6.84B
$47.2M 0.21%
+2,603,000
New +$46.1M
CNC icon
64
Centene
CNC
$32.5B
$46.3M 0.2%
614,917
-1,553,258
-72% -$114M
EDR
65
DELISTED
Endeavor Group Holdings, Inc.
EDR
$45.8M 0.2%
+1,605,000
New +$44.1M
CNTA
66
DELISTED
Centessa Pharmaceuticals
CNTA
$45M 0.2%
2,814,318
+818,318
+41% +$10M
BBIO icon
67
BridgeBio Pharma
BBIO
$16.5B
$44.5M 0.2%
+1,747,000
New +$45.9M
AXNX
68
DELISTED
Axonics, Inc. Common Stock
AXNX
$36M 0.16%
517,000
+147,000
+40% +$10.1M
LQDA icon
69
Liquidia Corp
LQDA
$8.02B
$32.9M 0.14%
3,290,956
+1,235,956
+60% +$13.5M
GDS icon
70
GDS Holdings
GDS
$6.41B
$31.2M 0.14%
1,531,133
+305,000
+25% +$4.31M
SIMO icon
71
Silicon Motion
SIMO
$8.68B
$31.2M 0.14%
514,000
-53,534
-9% -$3.53M
ENTA icon
72
Enanta Pharmaceuticals
ENTA
$400M
$21.8M 0.1%
2,108,262
+13,262
+0.6% +$173K
MTTR
73
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$19.6M 0.09%
+4,355,096
New +$19M
SVRA icon
74
Savara
SVRA
$1.19B
$19.3M 0.08%
4,560,000
– –
EVH icon
75
Evolent Health
EVH
$447M
$18.1M 0.08%
+639,000
New +$16.5M
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Farallon Capital Management held 187 positions worth $22.8B, down 2.2% from $23.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Farallon Capital Management withdrew a net $2.26B in Q3 2024, closing 22 positions and reducing 39 holdings. Its most notable exit was AstraZeneca, an estimated $188M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Woodward worth $198M.

  • Farallon Capital Management's largest Q3 2024 buy was Woodward: 1,154,000 shares worth $198M.
  • Farallon Capital Management added most to Walt Disney in Q3 2024, an estimated $207M increase.
  • Farallon Capital Management's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $294M.
  • Farallon Capital Management fully exited AstraZeneca in Q3 2024, selling an estimated $188M.
  • Farallon Capital Management's ten largest holdings make up 40% of its $22.8B portfolio in Q3 2024.
  • Farallon Capital Management opened 21 new positions and closed 22 in Q3 2024.
  • Farallon Capital Management's portfolio value fell 2.2% quarter-over-quarter to $22.8B.

Based on Farallon Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.